Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Chest
|
February 3, 2016
Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials
Jonathan A Rose, Jody M Cleveland, Youlan Rao, et al.
Pulmonary Circulation
|
June 13, 2017
Do single or sequential measurements of leptin and adiponectin in plasma have prognostic value in pulmonary arterial hypertension?
Adriano R Tonelli, Wassim H Fares, Wael Dakkak, et al.
Chest
|
March 9, 2026
The Minimal Important Difference in N-Terminal Pro-Brain Natriuretic Peptide in Pulmonary Hypertension
Matthew R Lammi, Sarah L Khan, Youlan Rao, et al.
International Journal of Cardiology
|
December 20, 2017
The impact of delayed treatment on 6-minute walk distance test in patients with pulmonary arterial hypertension: A meta-analysis
Carmine Dario Vizza, Roberto Badagliacca, Chad R Messick, et al.
Pulmonary Circulation
|
July 18, 2017
Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension
Jeffrey D Marshall, Maor Sauler, Adriano Tonelli, et al.
Pulmonary Circulation
|
November 4, 2021
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily
Shelley Shapiro, Stacy Mandras, Ricardo Restrepo-Jaramillo, et al.
Statistical Applications in Genetics and Molecular Biology
|
August 5, 2008
A comparison of normalization techniques for microRNA microarray data
Youlan Rao, Yoonkyung Lee, David Jarjoura, et al.
Pulmonary Circulation
|
April 27, 2018
Is hyponatremia associated with mortality in pulmonary arterial hypertension?
Anastasiia A Rudkovskaia, Adriano R Tonelli, Youlan Rao, et al.
The American Journal of Cardiology
|
May 21, 2020
PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial Hypertension
Katharine R Clapham, Youlan Rao, Sandeep Sahay, et al.
Advances in Therapy
|
January 10, 2024
Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension
Joan Barberà, Pavel Jansa, Elizabeth Klings, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Chest
|
February 3, 2016
Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials
Jonathan A Rose, Jody M Cleveland, Youlan Rao, et al.
Pulmonary Circulation
|
June 13, 2017
Do single or sequential measurements of leptin and adiponectin in plasma have prognostic value in pulmonary arterial hypertension?
Adriano R Tonelli, Wassim H Fares, Wael Dakkak, et al.
Chest
|
March 9, 2026
The Minimal Important Difference in N-Terminal Pro-Brain Natriuretic Peptide in Pulmonary Hypertension
Matthew R Lammi, Sarah L Khan, Youlan Rao, et al.
International Journal of Cardiology
|
December 20, 2017
The impact of delayed treatment on 6-minute walk distance test in patients with pulmonary arterial hypertension: A meta-analysis
Carmine Dario Vizza, Roberto Badagliacca, Chad R Messick, et al.
Pulmonary Circulation
|
July 18, 2017
Complexity of macrophage migration inhibitory factor (MIF) and other angiogenic biomarkers profiling in pulmonary arterial hypertension
Jeffrey D Marshall, Maor Sauler, Adriano Tonelli, et al.
Pulmonary Circulation
|
November 4, 2021
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily
Shelley Shapiro, Stacy Mandras, Ricardo Restrepo-Jaramillo, et al.
Statistical Applications in Genetics and Molecular Biology
|
August 5, 2008
A comparison of normalization techniques for microRNA microarray data
Youlan Rao, Yoonkyung Lee, David Jarjoura, et al.
Pulmonary Circulation
|
April 27, 2018
Is hyponatremia associated with mortality in pulmonary arterial hypertension?
Anastasiia A Rudkovskaia, Adriano R Tonelli, Youlan Rao, et al.
The American Journal of Cardiology
|
May 21, 2020
PECAM-1 is Associated WithOutcomes and Response to Treatment in Pulmonary Arterial Hypertension
Katharine R Clapham, Youlan Rao, Sandeep Sahay, et al.
Advances in Therapy
|
January 10, 2024
Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension
Joan Barberà, Pavel Jansa, Elizabeth Klings, et al.
Page
of 3